Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadashi Haraguchi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
PCN Reports : Psychiatry and Clinical Neurosciences|November 13, 2025
Bridging the service gap in cognitive behavioral therapy from a user perspective: Findings from a web-based survey in JapanTadashi Haraguchi
Psychiatry and Clinical Neurosciences|August 5, 2021
Has the 2016 expansion of mental disorders covered under national health insurance increased the use of cognitive behavioral therapy in Japan? An analysis of the National Open Data BaseTadashi Haraguchi, Naoki Yoshinaga, Yuta Hayashi, et al.
Behavioural and Cognitive Psychotherapy|February 23, 2011
Alterations of responsibility beliefs through cognitive-behavioural group therapy for obsessive-compulsive disorderTadashi Haraguchi, Eiji Shimizu, Hiroshi Ogura, et al.
Schizophrenia Research|December 12, 2012
Orbitofrontal cortex abnormality and deficit schizophreniaNobuhisa Kanahara, Yoshimoto Sekine, Tadashi Haraguchi, et al.
Psychiatry Research|March 16, 2013
Length of mechanical restraint following haloperidol injections versus oral atypical antipsychotics for the initial treatment of acute schizophrenia: a propensity-matched analysis from the Japanese diagnosis procedure combination databaseMitsuhiro Nakamura, Hideo Yasunaga, Tadashi Haraguchi, et al.
Psychiatry and Clinical Neurosciences|March 19, 2011
Attitudes of Japanese psychiatrists toward forensic mental health as revealed by a national surveyTadashi Haraguchi, Mihisa Fujisaki, Akihiro Shiina, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 29, 2009
Impaired P50 suppression in fear extinction in obsessive-compulsive disorderMakoto Nanbu, Taichi Kurayama, Ken Nakazawa, et al.
Annals of General Psychiatry|June 25, 2010
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophreniaAkihiro Shiina, Yukihiko Shirayama, Tomihisa Niitsu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
PCN Reports : Psychiatry and Clinical Neurosciences|November 13, 2025
Bridging the service gap in cognitive behavioral therapy from a user perspective: Findings from a web-based survey in JapanTadashi Haraguchi
Psychiatry and Clinical Neurosciences|August 5, 2021
Has the 2016 expansion of mental disorders covered under national health insurance increased the use of cognitive behavioral therapy in Japan? An analysis of the National Open Data BaseTadashi Haraguchi, Naoki Yoshinaga, Yuta Hayashi, et al.
Behavioural and Cognitive Psychotherapy|February 23, 2011
Alterations of responsibility beliefs through cognitive-behavioural group therapy for obsessive-compulsive disorderTadashi Haraguchi, Eiji Shimizu, Hiroshi Ogura, et al.
Schizophrenia Research|December 12, 2012
Orbitofrontal cortex abnormality and deficit schizophreniaNobuhisa Kanahara, Yoshimoto Sekine, Tadashi Haraguchi, et al.
Psychiatry Research|March 16, 2013
Length of mechanical restraint following haloperidol injections versus oral atypical antipsychotics for the initial treatment of acute schizophrenia: a propensity-matched analysis from the Japanese diagnosis procedure combination databaseMitsuhiro Nakamura, Hideo Yasunaga, Tadashi Haraguchi, et al.
Psychiatry and Clinical Neurosciences|March 19, 2011
Attitudes of Japanese psychiatrists toward forensic mental health as revealed by a national surveyTadashi Haraguchi, Mihisa Fujisaki, Akihiro Shiina, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 29, 2009
Impaired P50 suppression in fear extinction in obsessive-compulsive disorderMakoto Nanbu, Taichi Kurayama, Ken Nakazawa, et al.
Annals of General Psychiatry|June 25, 2010
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophreniaAkihiro Shiina, Yukihiko Shirayama, Tomihisa Niitsu, et al.
Pageof 1